Stonepine Capital Management, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1440771
BEND, OR
Position in XERS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$232,174
-$725,643 QoQ
Shares Held
40,030
-80.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Derivatives in XERS
reported options exposure · as of Mar 31, 2026CallValue
$1,624,000
CallShares
280,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Stonepine Capital Management, LLC holds $10,499,486 across 4 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (2.2% of the industry book) .
All Filings in XERS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,624,000 | 280,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $232,174 | 40,030 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $957,817 | 205,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $561,434 | 102,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $618,054 | 182,317 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $1,321,770 | 598,086 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,951,950 | 5,937,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,002,591 | 5,915,372 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $14,083,534 | 8,640,205 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,889,601 | 11,195,189 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,167,942 | 12,928,168 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,937,022 | 11,647,417 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,285,583 | 7,924,056 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,573,172 | 5,656,373 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||